BusinessActinium Pharmaceuticals to Host Webinar to Provide Update on Actimab-A Phase 2 Clinical TrialBy Nasdaq OMXSep 21, 2016, 12:01 PM UTC
BusinessActinium Pharmaceuticals Selects Vector Oncology as its Clinical Research Organization for Actimab-A Phase 2 TrialBy Nasdaq OMXSep 20, 2016, 11:02 AM UTC
BusinessActinium Pharmaceuticals to Present at Ladenburg Thalmann 2nd Annual Healthcare ConferenceBy Nasdaq OMXSep 19, 2016, 11:00 AM UTC
BusinessActinium Pharmaceuticals Presenting at Rodman & Renshaw 18th Annual Global Investment ConferenceBy Nasdaq OMXSep 13, 2016, 11:00 AM UTC
BusinessActinium Pharmaceuticals Presenting at the BioCentury 23rd Annual NewsMakers in the Biotech Industry ConferenceBy Nasdaq OMXSep 9, 2016, 11:00 AM UTC
BusinessActinium Enhances Capabilities with Hiring of Industry and Clinical Research Veterans to its Product Development and Clinical Development TeamsBy Nasdaq OMXSep 7, 2016, 11:00 AM UTC
